UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
89.60
+1.70 (1.93%)
Jan 22, 2026, 12:40 PM CST

UnicoCell Biomed Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
34.5831.8824.5914.48.183.98
Upgrade
Revenue Growth (YoY)
18.92%29.66%70.79%76.07%105.35%-74.70%
Upgrade
Cost of Revenue
11.1911.316.696.22.351.64
Upgrade
Gross Profit
23.3920.5717.98.25.832.34
Upgrade
Selling, General & Admin
38.0834.8531.425.423.321.94
Upgrade
Research & Development
102.0288.6482.7874.9169.8791.76
Upgrade
Operating Expenses
140.24123.49114.18100.3193.17113.69
Upgrade
Operating Income
-116.84-102.92-96.28-92.11-87.34-111.35
Upgrade
Interest Expense
-1.37-1.47-1.45-1.26-0.66-0.94
Upgrade
Interest & Investment Income
9.397.545.790.840.080.36
Upgrade
Currency Exchange Gain (Loss)
0.040.020.010.05--
Upgrade
Other Non Operating Income (Expenses)
4.15.133.041.181.542.73
Upgrade
EBT Excluding Unusual Items
-104.7-91.7-88.9-91.3-86.37-109.21
Upgrade
Gain (Loss) on Sale of Investments
-2.35-1.79-0.1--
Upgrade
Gain (Loss) on Sale of Assets
-0.414.79---
Upgrade
Other Unusual Items
---0.05--
Upgrade
Pretax Income
-107.04-93.07-84.11-91.16-86.37-109.21
Upgrade
Net Income
-107.04-93.07-84.11-91.16-86.37-109.21
Upgrade
Net Income to Common
-107.04-93.07-84.11-91.16-86.37-109.21
Upgrade
Shares Outstanding (Basic)
605754413836
Upgrade
Shares Outstanding (Diluted)
605754413836
Upgrade
Shares Change (YoY)
5.35%6.68%29.61%10.12%6.10%17.04%
Upgrade
EPS (Basic)
-1.79-1.62-1.56-2.20-2.29-3.07
Upgrade
EPS (Diluted)
-1.79-1.62-1.56-2.20-2.29-3.07
Upgrade
Free Cash Flow
-90.54-66.84-81.35-78.05-85.34-148.85
Upgrade
Free Cash Flow Per Share
-1.52-1.17-1.51-1.88-2.27-4.19
Upgrade
Gross Margin
67.65%64.52%72.78%56.93%71.32%58.71%
Upgrade
Operating Margin
-337.89%-322.83%-391.56%-639.78%-1068.08%-2796.43%
Upgrade
Profit Margin
-309.55%-291.94%-342.06%-633.15%-1056.30%-2742.57%
Upgrade
Free Cash Flow Margin
-261.83%-209.66%-330.82%-542.15%-1043.70%-3737.95%
Upgrade
EBITDA
-102.74-82.37-76.71-76.25-71.24-98.68
Upgrade
EBITDA Margin
-297.11%-258.35%----
Upgrade
D&A For EBITDA
14.120.5619.5715.8616.112.67
Upgrade
EBIT
-116.84-102.92-96.28-92.11-87.34-111.35
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.